DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Armodafinil

Armodafinil

  • Modafinil/Armodafinil (Provigil ® /Nuvigil

    Modafinil/Armodafinil (Provigil ® /Nuvigil

  • Amphetamine/Dextroamphetamine IR Generic

    Amphetamine/Dextroamphetamine IR Generic

  • MEDICATION GUIDE Armodafinil Tablets, C-IV Read the Medication Guide That Comes with Armodafinil Before You Start Taking It and Each Time You Get a Refill

    MEDICATION GUIDE Armodafinil Tablets, C-IV Read the Medication Guide That Comes with Armodafinil Before You Start Taking It and Each Time You Get a Refill

  • Nuvigil

    Nuvigil

  • 2010 Buenos Aires, Argentina

    2010 Buenos Aires, Argentina

  • Stimulant and Related Medications: US Food and Drug

    Stimulant and Related Medications: US Food and Drug

  • Monoamine Reuptake Inhibitors in Parkinson's Disease

    Monoamine Reuptake Inhibitors in Parkinson's Disease

  • (12) Patent Application Publication (10) Pub. No.: US 2009/0005722 A1 Jennings-Spring (43) Pub

    (12) Patent Application Publication (10) Pub. No.: US 2009/0005722 A1 Jennings-Spring (43) Pub

  • Sodium Oxybate (Xyrem®) Armodafinil (Nuvigil®) Solriamfetol (Sunosi®) Approval December 1998 July 2002 June 2007 March 2019 Cephalon, Inc

    Sodium Oxybate (Xyrem®) Armodafinil (Nuvigil®) Solriamfetol (Sunosi®) Approval December 1998 July 2002 June 2007 March 2019 Cephalon, Inc

  • Review Article Monoamine Reuptake Inhibitors in Parkinson's Disease

    Review Article Monoamine Reuptake Inhibitors in Parkinson's Disease

  • World of Cognitive Enhancers

    World of Cognitive Enhancers

  • Paincomp® Thresholds V04.14.2021 Copyright © 2020 Aegis Sciences

    Paincomp® Thresholds V04.14.2021 Copyright © 2020 Aegis Sciences

  • FDA Approved Labeling Text for NDA 21-875/NUVIGIL™ (Armodafinil) Tablets Approved Labeling Dated June 15, 2007

    FDA Approved Labeling Text for NDA 21-875/NUVIGIL™ (Armodafinil) Tablets Approved Labeling Dated June 15, 2007

  • CUSTOMS TARIFF - SCHEDULE 99 - I

    CUSTOMS TARIFF - SCHEDULE 99 - I

  • NUVIGIL C-IV (Armodafinil) Tablets

    NUVIGIL C-IV (Armodafinil) Tablets

  • CE-123 on Mesocorticolimbic Dopamine System

    CE-123 on Mesocorticolimbic Dopamine System

  • Dementia and Antipsychotic Treatment: Literature Search Strategies

    Dementia and Antipsychotic Treatment: Literature Search Strategies

  • 11-14 February 2019 PRAC Meeting Minutes

    11-14 February 2019 PRAC Meeting Minutes

Top View
  • International Dementia with Lewy Bodies Conference Fort Lauderdale, Florida, USA; December 1 – 4, 2015
  • Nuvigil® /Armodafinil Provigil®/Modafinil
  • PRAC Draft Agenda of Meeting 11-14 February 2019
  • Armodafinil, Sunosi
  • NUVIGIL® (Armodafinil) Tablets, for Oral Use, C-IV Discontinue NUVIGIL
  • A Practical Guide to the Therapy of Narcolepsy and Hypersomnia Syndromes
  • The Medication Guide for a Safe Recovery
  • Armodafinil Useful Adjunct to CPAP in Apnea
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Modulation of Fronto-Cortical Activity by Modafinil: a Functional Imaging and Fos Study in the Rat
  • Nuvigil® /Armodafinil Provigil®/Modafinil
  • The Effect of Adjunctive Armodafinil on Cognitive Performance And
  • (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
  • Customs Tariff - Schedule Xxi - 1
  • All Requests for Provigil (Modafinil) and Nuvigil (Armodafinil) Require A
  • Modafinil / Armodafinil for Employer Group Plans
  • Modafinil and Armodafinil
  • Stimulants and Related Agents


© 2024 Docslib.org    Feedback